1. solis /
The procedures for the issuance of a notification regarding the registration status of a product shall be determined by the Cabinet of Ministers of the Republic of Latvia Regulation No 436 of 26 June 2007, Procedures for the Import and Export of Medicinal Products, Section IV, Export of Medicinal Products, Clauses 33, 35, 37, 38 and 38.3.
1. In order to receive a notification regarding the status of registration of the product, a person shall submit an application to the State Agency of Medicines (ZVA) for receipt of the notification.
The application must be signed with a secure electronic signature (a) or in paper format (b):
a) When using the ZVA e-address or e-mail email@example.com, please sign the letter with a secure electronic signature (created by reliable means of creating an electronic signature and certified by a qualified certificate).
(b) The application signed in paper format may be submitted to ZVA (office 11) or sent by post, ZVA address: Jersik Street 15, Riga LV-1003.
2. The submission must contain all the information requested in Paragraph 37 of the Cabinet of Ministers of the Republic of Latvia Regulation No 436 of 26 June 2007, Procedures for the Import and Export of Medicinal Products.
3. Data required for a product registration statement by sending them in electronic format to the ZVA e-address or e-mail address: firstname.lastname@example.org
Documents to be submitted